Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 6/20 | 0.81 |
| ▸ | CNR1 | P21554 | 1/20 | 0.78 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.75 |
| ▸ | MMP13 | P45452 | 1/20 | 0.69 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | MAOA | P21397 | 1/20 | 0.69 |
| ▸ | MAOB | P27338 | 1/20 | 0.69 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.65 |
| ▸ | IGF1R | P08069 | 1/20 | 0.61 |
| ▸ | PIM1 | P11309 | 1/20 | 0.60 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8159450 | 1.00 | HPGD (0.81) | HPGDCNR1PTPN1MMP13ADAMTS5 | |
| SCHEMBL9433307 | 0.93 | CNR1 (0.81) | HPGDCNR1PTPN1MMP13ADAMTS5 | |
| SCHEMBL1248799 | 0.93 | CNR1 (0.81) | HPGDCNR1PTPN1MMP13ADAMTS5 | |
| SCHEMBL1248797 | 0.93 | CNR1 (0.81) | HPGDCNR1PTPN1MMP13ADAMTS5 | |
| SCHEMBL1299995 | 0.90 | HPGD (1.00) | HPGDPTPN1MMP13POLBMAOA | |
| SCHEMBL12107587 | 0.90 | HPGD (1.00) | HPGDPTPN1MMP13POLBMAOA | |
| SCHEMBL1299994 | 0.90 | HPGD (1.00) | HPGDPTPN1MMP13POLBMAOA | |
| SCHEMBL8159453 | 0.87 | HPGD (0.60) | HPGDCNR1PTPN1MMP13ADAMTS5 | |
| SCHEMBL18504345 | 0.84 | IDH1 (0.81) | HPGDCNR1PTPN1MMP13ADAMTS5 | |
| SCHEMBL6923861 | 0.83 | CNR1 (0.80) | HPGDCNR1PTPN1MMP13ADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2000511883-A | — | — | 2000-09-12 | — | — | JP | claimed |
| US-6063800-A | Modulators of molecules with phosphotyrosine recognition units | NOVO NORDISK A/S (DK) | 2000-05-16 | — | — | US | claimed |
| WO-1997040017-A2 | MODULATORS OF MOLECULES WITH PHOSPHOTYROSINE RECOGNITION UNITS | NOVO NORDISK A/S (DK) | 1997-10-30 | — | — | WO | claimed |
| US-6080770-A | SUBSTITUTED 1,2,3-TRIAZOLE OR 1,2,4-TRIAZOLE COMPOUND | NOVO NORDISK A/S (DK) | 2000-06-27 | — | — | US | disclosed |
| US-6063800-A | Modulators of molecules with phosphotyrosine recognition units | NOVO NORDISK A/S (DK) | 2000-05-16 | — | — | US | disclosed |
| US-5972978-A | FOR USE IN TREATMENT OF HUMAN AND ANIMAL DISORDERS, USE FOR PURIFICATION OF PROTEINS OR GLYCOPROTEINS, USE IN DIAGNOSIS | NOVO NORDISK A/S (DK) | 1999-10-26 | — | — | US | disclosed |
| US-5958957-A | PROTEIN TYROSINE PHOSPHATASES, PROTEINS WITH SRC-MONOLOGY 2-DOMAINS; ANTICARCINOGENIC,-TUMOR AND DIABETIC AGENTS; PURIFICATION OF PROTEINS AND GLYCOPROTEINS; MEDICAL DIAGNOSIS | NOVO NORDISK A/S (DK) | 1999-09-28 | — | — | US | disclosed |
| WO-1997040017-A2 | MODULATORS OF MOLECULES WITH PHOSPHOTYROSINE RECOGNITION UNITS | NOVO NORDISK A/S (DK) | 1997-10-30 | — | — | WO | disclosed |